Wave Life Sciences Ltd.·4

Mar 5, 8:40 PM ET

Panzara Michael A. 4

4 · Wave Life Sciences Ltd. · Filed Mar 5, 2020

Insider Transaction Report

Form 4
Period: 2020-03-03
Panzara Michael A.
Franchise Lead, Neurology
Transactions
  • Award

    Share Option (right to buy)

    2020-03-03+36,00036,000 total
    Exercise: $8.17Exp: 2030-03-03Ordinary Shares (36,000 underlying)
Footnotes (1)
  • [F1]The option vests as to 50% of the shares on February 1, 2021 and 50% on February 1, 2022

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION